Sunil Healthcare Ltd (537253)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Sunil Healthcare's revenue was ₹19.0 Cr (-16.1% year on year, -3.7% on the previous quarter), and net profit ₹0.5 Cr (-49.1% year on year); the operating margin was 15.4%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹19.0 | -16.1% | -3.7% |
| Operating profit | ₹2.9 | -10.5% | +50.9% |
| Net profit | ₹0.5 | -49.1% | -69.5% |
| EPS (₹) | 0.45 | -49.4% | -69.6% |
| Operating margin | 15.4% | — | — |
📢 Recent Corporate Announcements
Sunil Healthcare Ltd has reported an upgrade in its credit ratings for bank facilities by Brickwork Ratings India Pvt. Ltd., effective October 3, 2026. The long-term bank facilities have been upgraded to 'BWR BBB-' with a Stable outlook from the earlier 'CARE BB+' (Stable) assigned by CARE Ratings. The short-term bank facilities have been upgraded to 'BWR A3' from the previous 'CARE A4+'. This transition moves the company's long-term bank borrowing rating back into investment grade across its Rs 56 crore debt profile.
- Long-term bank facilities upgraded to 'BWR BBB-' with Stable outlook from earlier 'CARE BB+'
- Short-term bank facilities upgraded to 'BWR A3' from earlier 'CARE A4+'
- Rating revision executed by Brickwork Ratings India Pvt. Ltd. via letter dated October 01, 2026
- Rating changes took effect from October 03, 2026
Sunil Healthcare reported a weak set of numbers for Q1 FY27, with consolidated revenue declining 16.2% YoY to Rs 18.98 Cr. Net profit saw a sharp contraction of 71.4% YoY, falling to Rs 0.26 Cr from Rs 0.91 Cr in the same period last year. The bottom line was pressured by high finance costs of Rs 1.66 Cr, which represent nearly 9% of the quarterly revenue. Additionally, the company noted a tax adjustment related to the valuation of leasehold land under the Income Tax Act 2025.
- Consolidated Revenue from operations decreased 16.2% YoY to Rs 18.98 Cr from Rs 22.64 Cr.
- Consolidated Net Profit fell 71.4% YoY to Rs 0.26 Cr from Rs 0.91 Cr.
- Finance costs stood at Rs 1.66 Cr for the quarter, significantly impacting profitability.
- Total expenses for the quarter were Rs 18.96 Cr on a standalone basis.
- The 52nd Annual General Meeting is scheduled for September 2026 (document contains conflicting dates of 21st and 28th).
Sunil Healthcare reported a weak set of numbers for Q1 FY27, with consolidated revenue declining 16.1% YoY to Rs 18.99 Cr. Net profit saw a sharper decline of 44% YoY, falling to Rs 0.51 Cr from Rs 0.91 Cr in the same quarter last year. Profitability was impacted by lower scale and high finance costs of Rs 1.66 Cr, which consumed a significant portion of operating gains. The company has opted for the lower tax regime under Section 115BAA, which influenced the deferred tax calculations this quarter.
- Consolidated Revenue from operations fell to Rs 18.99 Cr, a 16.1% decline compared to Rs 22.64 Cr in Q1 FY26.
- Consolidated Net Profit decreased by 44% YoY to Rs 0.51 Cr from Rs 0.91 Cr.
- Finance costs remained high at Rs 1.66 Cr, representing approximately 8.7% of the total quarterly revenue.
- Earnings Per Share (EPS) for the quarter stood at Rs 0.50, down from Rs 0.89 in the year-ago period.
- The company's foreign subsidiaries in Mexico and North America contributed a combined net loss of Rs 4.75 lakhs.
Sunil Healthcare has scheduled a board meeting on August 13, 2026, to consider and approve the un-audited financial results for the first quarter ended June 30, 2026. This follows a turnaround year in FY26 where the company reported a net profit of ₹4.01 crore compared to a loss of ₹1.42 crore in FY25. The trading window for insiders remains closed from July 1, 2026, until August 15, 2026. Investors will be monitoring if the company can sustain its TTM operating margin of 14.5% in the new fiscal year.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results
- Trading window closure period from July 1, 2026, to August 15, 2026
- Company reported TTM revenue of ₹88 crore as of the latest financial context
- FY26 annual net profit stood at ₹4.01 crore, marking a recovery from previous losses
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
